Categories: DeliveryExtensionProductTechnology
Vantis Vascular, Inc. – Vantis Vascular is revolutionizing the treatment of complex and calcified arteries with next-generation technology that allows physicians to experience superior delivery, safety and efficiency. Crossfast, the Company’s first product is a next generation guide extension catheter to enable the delivery of balloon catheters and stents when additional guide support is needed
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.12.2024 | Series B | $10M | - |
| 21.05.2024 | - | $5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 17.12.2024 | Vantis Vascular Closes $10M in Series B-1 Funding | Vantis Vascular, a San Jose, CA-based medical technology company, raised $10M in Series B-1 Funding, following a raise of $30M to date from high-net-worth individuals and National Institute of Health grants.
Led by CEO Jason Turner, Vantis ... |
| 12.12.2024 | Vantis Vascular Scoops Up $10M Series B-1 |
SAN JOSE, CA, Vantis Vascular today announced the successful closing of $10 million Series B-1 preferred financing.
>> Click here for more funding data on Vantis Vascular
>> To export Vantis Vascular funding data to PDF and Exc... |
| 21.05.2024 | Vantis Secures $5M in Safe Financing | Vantis, a San Jose, CA-based medical technology company, raised $5M in Safe (Simple Agreement for Future Equity) financing.
With this funding, which followed a total raise of $24M to date from individuals and NIH grants, the company intends... |
| - | Vantis Vascular | “Home - Vantis Vascular” |
Reviews 0